Aziyo Biologics to Report First Quarter 2022 Financial Results on Monday, May 9, 2022
April 25, 2022 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., April 25, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of...
Aziyo Biologics Announces Upcoming KOL Call Hosted by Cowen
April 12, 2022 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., April 12, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of...
Aziyo Announces FDA 510(k) Submission for CanGaroo® RM, its Next-Generation Biomaterial Envelope Enhanced with Antibiotics
April 04, 2022 08:00 ET
|
Aziyo Biologics
SILVER SPRING, Md., April 04, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), today announced the Company has filed a 510(k) premarket notification to the U.S. Food and Drug...
Aziyo Biologics to Participate in the Lytham Partners Spring 2022 Investor Conference
March 31, 2022 18:50 ET
|
Aziyo Biologics
SILVER SPRING, Md., March 31, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of...
Aziyo Biologics Reports Fourth Quarter and Full Year 2021 Financial Results
March 03, 2022 16:01 ET
|
Aziyo Biologics
SILVER SPRING, Md., March 03, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of...
Aziyo Biologics to Participate in the Cowen 42nd Annual Health Care Conference
February 23, 2022 16:01 ET
|
Aziyo Biologics
SILVER SPRING, Md., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated...
Aziyo Biologics to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 3, 2022
February 17, 2022 16:01 ET
|
Aziyo Biologics
SILVER SPRING, Md., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated...
Aziyo Biologics to Present at the H.C. Wainwright Bioconnect Virtual Conference
December 27, 2021 16:01 ET
|
Aziyo Biologics
SILVER SPRING, Md., Dec. 27, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated...
Aziyo Biologics Announces Closing of $14.0 Million Private Placement
December 08, 2021 17:31 ET
|
Aziyo Biologics
SILVER SPRING, Md., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (the “Company”), a commercial-stage regenerative medicine company focused on creating the next generation of...
Aziyo Biologics Announces $14.0 Million Private Placement
December 06, 2021 06:59 ET
|
Aziyo Biologics
SILVER SPRING, Md., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (the “Company”) today announced that it has entered into a definitive agreement to sell securities in a private placement...